key: cord-1007185-nnp7yl2w authors: Odille, Geoffrey; Girard, Noémie; Sanchez, Stephane; Lelarge, Sarah; Mignot, Alexandre; Putot, Sophie; Larosa, Fabrice; Vovelle, Jeremie; Nuss, Valentine; Da Silva, Sofia; Barben, Jeremy; Manckoundia, Patrick; Putot, Alain title: Comment on: Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores date: 2021-01-22 journal: J Am Geriatr Soc DOI: 10.1111/jgs.17030 sha: c83c4f2a447ae49ce6a82165b783c1a0f1a08da9 doc_id: 1007185 cord_uid: nnp7yl2w See the Reply by De Matteis et al. agree with the authors that the easy-to-use qCSI, which uses three every-day clinical measures, is of particular interest. As underscored by the authors, short-term prognosis is mainly driven by respiratory state, even in older patients. Additionally, the best prognostic scores mainly explore respiratory function, which is mostly clinically evaluated by bedside parameters. The World Health Organization (WHO) propose an easy-to-use severity scale in their COVID-19 clinical guidance, based solely on respiratory evaluation (S1: no pneumonia; S2: pneumonia, with SpO2 ≥ 90% on room air; S3: severe pneumonia, with respiratory rate > 30 breaths/min or SpO2 < 90% on room air; S4: critical disease, with acute respiratory distress syndrome). 6 To our knowledge, this pragmatic scale has not yet been evaluated in a geriatric setting. In a multicenter observational study of patients aged more than 75 in COVID-19 geriatric units of four French hospitals, we sought to evaluate the WHO severity scale specifically in a very old population, compared with other usual prognostic tools frequently used in COVID-19, including pneumonia severity index, 7 NEWS, 4 qCSI, 5 quick SOFA (qSOFA), 8 and CURB65. 9 We included all consecutive patients aged more than 75 years and hospitalized for COVID-19 (with positive RT-PCR test). Clinical presentation and comorbidities were recorded at admission to build prognostic scores. An AUROC analysis was used to compare the ability of the various scores to predict 1-month mortality. This study was approved by the local ethics committee. We included 142 consecutive patients (median age 86 years) who were then followed up for 1 month after admission. Overall, 48 (33.8%) patients had died by the end of followup. As shown in Figure 1 , the WHO severity scale at admission predicted short-term mortality remarkably well. When compared with the more complex pneumonia severity index 7 (AUROC 0.74 (0.60-0.88)), the WHO severity scale (0.70 (0.60-0.79)) had similar performance when it was used to predict 1-month mortality. NEWS (0.66 (0.55-0.77)), qCSI (0.65 (0.54-0.76)), qSOFA (0.61 (0.50-0.72)), and CURB65 (0.51 (0.40-0.62)) were of lower interest in this very old comorbid population, and did not reach the performance described by Covino et al. for in-hospital mortality in younger patients. In conclusion, these findings support the use of a simple evaluation based on respiratory function to determine prognosis after COVID-19. For this purpose, the WHO severity scale was found to have satisfactory performance in a geriatric setting. More complex evaluations that are difficult to implement at the bedside, especially in such a sanitary crisis, do not appear to add prognostic value in the short term, even in frail older patients. Predicting in-hospital mortality in COVID-19 older patients with specifically developed scores Risk stratification of patients admitted to hospital with Covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19 The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death Development and validation of the quick COVID-19 severity index: a prognostic tool for early clinical decompensation Clinical management of COVID-19 A prediction rule to identify low-risk patients with community-acquired pneumonia The third international consensus definitions for sepsis and septic shock (Sepsis-3) Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study The authors thank Suzanne Rankin for the English review of the manuscript.Conflict of Interest: The authors declare no conflict of interest.Author Sponsor's Role: None.